Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
19621
Meta data to Fig 4.
Published 2024“…Using the zebrafish pectoral fin bud as a model for early vertebrate fin/limb development, we found that K<sup>+</sup> channels also scale this anatomical structure, and we determined how one K<sup>+</sup>-leak channel, Kcnk5b, integrates into its developmental program. …”
-
19622
Meta data to Fig 6.
Published 2024“…Using the zebrafish pectoral fin bud as a model for early vertebrate fin/limb development, we found that K<sup>+</sup> channels also scale this anatomical structure, and we determined how one K<sup>+</sup>-leak channel, Kcnk5b, integrates into its developmental program. …”
-
19623
-
19624
-
19625
-
19626
-
19627
-
19628
-
19629
Supplementary Figures 1-5 from A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance
Published 2023“…Supplemental Figure 4: BJAB-LexR cells have increased SLC26A2 and decreased DR4 and DR5. Supplemental Figure 5: SLC26A2 expression correlates with Metastasis prognosis.…”
-
19630
-
19631
-
19632
Pre-treatment with GnRHa or <i>ulipristal acetate</i> prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis
Published 2017“…Pre-treatment with GnRHa before laparoscopic myomectomies also shows a reduction in intra-operative blood loss by 23.03ml (95% CI -40.79 to -5.27) and in the frequency of blood transfusions (OR 0.17, 95% CI 0.05 to 0.55) compared to no pre-treatment.…”
-
19633
Data of GO analysis.
Published 2024“…Here, we generated KO mice of other <i>Garins</i>, namely <i>Garin2</i>, <i>Garin3</i>, <i>Garin4</i>, <i>Garin5a</i>, and <i>Garin5b</i> (<i>Garin2-5b</i>). …”
-
19634
Sequences used for phylogenetic analyses.
Published 2024“…Here, we generated KO mice of other <i>Garins</i>, namely <i>Garin2</i>, <i>Garin3</i>, <i>Garin4</i>, <i>Garin5a</i>, and <i>Garin5b</i> (<i>Garin2-5b</i>). …”
-
19635
Image3_Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile.jpeg
Published 2023“…The reported data on exacerbations showed an overall improvement in the exacerbation rate with a decreased use of inhaled steroids and some other minimal clinically important difference (MCID).…”
-
19636
Image1_Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile.jpeg
Published 2023“…The reported data on exacerbations showed an overall improvement in the exacerbation rate with a decreased use of inhaled steroids and some other minimal clinically important difference (MCID).…”
-
19637
Image2_Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile.jpeg
Published 2023“…The reported data on exacerbations showed an overall improvement in the exacerbation rate with a decreased use of inhaled steroids and some other minimal clinically important difference (MCID).…”
-
19638
-
19639
-
19640